Nutranomics Appoints MD and PhD Microbiologist as Supply Chain Manager
DRAPER, Utah, Dec. 6, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to report that it has appointed Enkhmart (Michelle) Dudleenamjil, MD, Ph.D., to the position of Supply Chain Manager.
"Michelle brings a wealth of knowledge and nutraceutical industry experience to Nutranomics, including a Ph.D. from Brigham Young University in microbiology and several published scientific papers related to inter-cellular transport," stated Nutranomics CEO, Dr. Tracy K. Gibbs. "I am confident that her superior technical expertise, and strong product development and marketing skills will make her a critical member of our team working with customers, suppliers, and manufacturers to build the best whole foods products in the industry."
Prior to joining Nutranomics, Dr. Dudleenamjil was Manager of Technical Services of Sabinsa Corporation, a Utah based manufacturer, supplier, and marketer of nutraceutical products for the nutritional, cosmetic, pharmaceutical, and food industries. While with Sabinsa, Dr. Dudleenamjil researched unique medicinal plants, their mechanisms of action and implementation of them in health supporting formulas. During this time, she also trained sales and customer service departments, prepared manuscripts and brochures, and assisted with new product development and marketing. Dr. Dudleenamjil received her Doctor of Medicine degree from Medical University of Mongolia, Ulaanbaatar, Mongolia, and a Ph.D. in Microbiology from Brigham Young University, Provo, Utah.
Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia.
For further information regarding Nutranomics, Inc., please contact our investor relations representatives at firstname.lastname@example.org or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, but are not limited to, expectations of future sales and profits. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
SOURCE Nutranomics, Inc.